Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20043Active, not recruiting
Randomised, double-blind trial in vulvar intraepithelial neoplasia (VIN) comparing Imiquimod 5% cream with Placebo cream (2 arms). Primary endpoint: Reduction in lesion size. Started Apr 2001; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20043.